Concepedia

Titration Schedules

Titration Schedules is a systematic framework used in variable-rate disease treatment to dynamically adjust therapeutic dosages over time based on patient-specific clinical responses and biomarker trajectories, distinguishing it from fixed or empirically derived dosing regimens.

188

Publications

8.8K

Citations

1.2K

Authors

635

Institutions

Publications per year

2017–2026

42

Parents

Publications

188

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Michaëla Diamant, Luc Van Gaal, Stephen Stranks et al. · The Lancet · 2010 · 436 citations

, , +14

A Randomized, Double-blind, Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events

Richard B. Dewey, J. Thomas Hutton, Peter A. LeWitt et al. · Archives of Neurology · 2001 · 241 citations

, , +15

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis

Gregory Klein, Paul Delmar, Nicola Voyle et al. · Alzheimer s Research & Therapy · 2019 · 213 citations · Full text

, , +17

Department of veterans affairs single-drug therapy of hypertension studyRevised figures and new data

Barry J. Materson, D REDA, William C. Cushman · American Journal of Hypertension · 1995 · 206 citations

, , +15

Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

Juan P. Frías, Michael A. Nauck, Joanna Van et al. · Diabetes Obesity and Metabolism · 2020 · 206 citations · Full text

, , +14

1–5 of 188

Authors

1.2K

  1. CU
    Christoph U. Correll

    Zucker Hillside Hospital, United States

    3 publications · 173 citations

    3

    h-index

  2. JD
    Jasper Dingemanse

    Actelion (Switzerland), Switzerland

    3 publications · 102 citations

    3

    h-index

  3. JA
    J. Atherton

    Royal Brisbane and Women's Hospital, Australia

    2 publications · 66 citations

    2

    h-index

  4. PE
    Paul E. Keck

    University of Cincinnati Medical Center, United States

    2 publications · 99 citations

    2

    h-index

  5. CD
    Charles Denaro

    The University of Queensland, Australia

    2 publications · 66 citations

    2

    h-index

1–5 of 1.2K

Institutions

635

  1. Eli Lilly (United States)

    Indianapolis, United States

    9 h-index

    36 publications

    3.8K citations

  2. Inserm

    Paris, France

    5 h-index

    8 publications

    415 citations

  3. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    5 h-index

    25 publications

    1.2K citations

  4. Radboud University Nijmegen

    Nijmegen, The Netherlands

    5 h-index

    16 publications

    990 citations

  5. Janssen (United States)

    Hopewell, United States

    5 h-index

    26 publications

    2.3K citations

  6. University of Toronto

    Toronto, Canada

    4 h-index

    15 publications

    1.8K citations

  7. Radboud University Medical Center

    Nijmegen, The Netherlands

    4 h-index

    9 publications

    532 citations

  8. The University of Texas Southwestern Medical Center

    Dallas, United States

    4 h-index

    4 publications

    494 citations

1–8 of 635

Venues

  1. PubMed

    Repository · 13 publications · 595 citations

    12

    h-index

  2. Current Medical Research and Opinion

    CMRO · 6 publications · 101 citations

    6

    h-index

  3. Investigational New Drugs

    4 publications · 168 citations

    4

    h-index

  4. Epilepsia

    4 publications · 304 citations

    4

    h-index

  5. The Journal of Clinical Pharmacology

    4 publications · 113 citations

    4

    h-index

1–5